Sex disparities in cardiac sarcoidosis patients undergoing implantable cardioverter‐defibrillator implantation

Abstract Introduction In patients with cardiac sarcoidosis (CS), implantable cardioverter‐defibrillators (ICDs) are important for preventing sudden cardiac death. This study aimed to investigate sex disparities in CS patients undergoing ICD implantation. Methods The 2016–2020 National Inpatient Samp...

Full description

Saved in:
Bibliographic Details
Published in:Pacing and clinical electrophysiology 2024-07
Main Authors: Ahmed, Raheel, Jamil, Yumna, Ramphul, Kamleshun, Mactaggart, Sebastian, Bilal, Maham, Singh Dulay, Mansimran, Shi, Rui, Azzu, Alessia, Okafor, Joseph, Memon, Rahat A, Sakthivel, Hemamalini, Khattar, Rajdeep, Wells, Athol Umfrey, Baksi, John Arun, Wechalekar, Kshama, Kouranos, Vasilis, Chahal, Anwar, Sharma, Rakesh
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Introduction In patients with cardiac sarcoidosis (CS), implantable cardioverter‐defibrillators (ICDs) are important for preventing sudden cardiac death. This study aimed to investigate sex disparities in CS patients undergoing ICD implantation. Methods The 2016–2020 National Inpatient Sample (NIS) database compared the characteristics and outcomes of males and females with CS receiving ICDs. Results Among 760 CS patients who underwent inpatient ICD implantation, 66.4% were male. Males were younger (55.0 vs. 56.9 years, p  
ISSN:0147-8389
1540-8159
1540-8159
DOI:10.1111/pace.15051